Mapping of serotonin 5‐HT4 receptor mRNA and ligand binding sites in the post‐mortem human brain

The anatomical localization of 5‐HT4 receptor mRNA and 5‐HT4 receptor protein was examined in sections of post‐mortem human brain by in situ hybridization histochemistry and radioligand receptor autoradiography. In the in situ hybridization study, the highest levels of 5‐HT4 receptor mRNA were found in caudate nucleus, putamen, nucleus accumbens, and in the hippocampal formation. No 5‐HT4 receptor mRNA was detected in globus pallidus and substantia nigra. For receptor autoradiography, two new and highly selective radioligands were compared: [3H]prucalopride, which preferentially labels the G‐protein coupled fraction of receptors, and [3H]R116712, which labels the entire receptor population at subnanomolar concentrations. [3H]Prucalopride and [3H]R116712 binding was performed on human brain hemisphere sections. The highest densities for both radioligands were found in the basal ganglia (caudate nucleus, putamen, nucleus accumbens, globus pallidus, substantia nigra). Moderate to low densities were detected in the hippocampal formation and in the cortical mantle. Mismatches between 5‐HT4 receptor mRNA and binding sites in the globus pallidus and the substantia nigra suggested that the binding sites may be localized on axonal projections originating from the striatum. To compare densities of binding sites, concentration binding curves with [3H]prucalopride, [3H]R116712 and [3H]GR113808 were performed on membranes from homogenates of several human brain regions. Comparison of Bmax‐values obtained with [3H]prucalopride and [3H]R116712 indicated that the G‐protein coupled fraction of 5‐HT4 receptors in the substantia nigra was exceptionally high (54%) in comparison with percentages (16–27%) found in the frontal cortex, the striatum and the hippocampus. Such a high percentage (40%) of [3H]prucalopride vs. [3H]R116712 binding was also observed in the substantia nigra in the receptor autoradiography experiments. The [3H]prucalopride binding was GppNHp‐sensitive, whereas [3H]R116712 and [3H]GR113808 was not. These data indicate that in the substantia nigra 5‐HT4 receptors are more strongly coupled to their signal transduction pathway than in other brain regions. Synapse 36:35–46, 2000. © 2000 Wiley‐Liss, Inc.

[1]  P. Salin,et al.  Lesion Study of the Distribution of Serotonin 5‐HT4 Receptors in Rat Basal Ganglia and Hippocampus , 1996, The European journal of neuroscience.

[2]  R. Hen,et al.  The mouse 5-hydroxytryptamine 1B receptor is localized predominantly on axon terminals , 1994, Neuroscience.

[3]  J. Palacios,et al.  Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry. , 1996, Brain research. Molecular brain research.

[4]  J. Roberts,et al.  Localization of serotonin-4 receptors in the striatonigral pathway in rat brain , 1995, Neuroscience.

[5]  M. Pompeiano,et al.  Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. , 1994, Brain research. Molecular brain research.

[6]  L. Prézeau,et al.  A Cluster of Basic Residues in the Carboxyl-terminal Tail of the Short Metabotropic Glutamate Receptor 1 Variants Impairs Their Coupling to Phospholipase C* , 1998, The Journal of Biological Chemistry.

[7]  J. Bockaert,et al.  Cloning and expression of human 5‐HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase , 1997, Neuroreport.

[8]  E. Wong,et al.  Central 5-HT4 receptors. , 1995, Trends in pharmacological sciences.

[9]  A. Nieoullon,et al.  Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain , 1994, Neuropharmacology.

[10]  J. Schuurkes.  Effect of cisapride on gastric motility. , 1990, Zeitschrift fur Gastroenterologie.

[11]  G. Sedvall,et al.  Autoradiography with saturation experiments of 11C-Ro 15–1788 binding to human brain sections , 1991, Journal of Neuroscience Methods.

[12]  J. Bockaert,et al.  A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930. , 1988, European journal of pharmacology.

[13]  W. Bax,et al.  5-Hydroxytryptamine stimulates human isolated atrium but not ventricle. , 1993, European journal of pharmacology.

[14]  M. Pompeiano,et al.  Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites , 1990, Brain Research.

[15]  J. Palacios,et al.  Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain , 1994, Neuropharmacology.

[16]  G F Pinto,et al.  A microcomputer program for fitting enzyme inhibition rate equations. , 1987, Computers in biology and medicine.

[17]  P. Bonaventure,et al.  Detailed mapping of serotonin 5-HT1B and 5-HT1D receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function , 1997, Neuroscience.

[18]  H. Kao,et al.  The 5‐HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. , 1995, The EMBO journal.

[19]  D. Dorsa,et al.  Colocalization of serotonin receptor subtypes 5‐HT2A, 5‐HT2C, and 5‐HT6 with neuropeptides in rat striatum , 1996, The Journal of comparative neurology.

[20]  H. Ladinsky,et al.  5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. , 1994, Neuroreport.

[21]  E. Wong,et al.  Quantitative autoradiography of 5-HT4 receptors in brains of three species using two structurally distinct radioligands, [3H]GR113808 and [3H]BIMU-1 , 1994, Neuropharmacology.

[22]  J. Gale,et al.  GR113808: a novel, selective antagonist with high affinity at the 5‐HT4 receptor , 1994, British journal of pharmacology.

[23]  G. Martin,et al.  5-HT Receptor Classification and Nomenclature: Towards a Harmonization with the Human Genome , 1997, Neuropharmacology.

[24]  J. Bockaert,et al.  Cloning, expression and pharmacology of the mouse 5‐HT4L receptor , 1996 .

[25]  Christer Halldin,et al.  Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain , 1994, Neuropsychopharmacology.

[26]  A. Meneses,et al.  Effects of 5-HT4 Receptor Agonists and Antagonists in Learning , 1997, Pharmacology Biochemistry and Behavior.

[27]  J. Bockaert,et al.  Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives. , 1990, Molecular pharmacology.

[28]  D. Clarke,et al.  The 5‐HT4 Receptor , 1993, Medicinal research reviews.

[29]  J. Bockaert,et al.  [3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain. , 1993, Neuroreport.

[30]  E. Marchetti-Gauthier,et al.  BIMU1 Increases Associative Memory in Rats by Activating 5-HT4 Receptors , 1997, Neuropharmacology.

[31]  J. Bockaert,et al.  A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. , 1988, Molecular pharmacology.

[32]  G. Sanger,et al.  SB-204070: 5-HT4 receptor antagonists and their potential therapeutic utility , 1994 .

[33]  G. Reynolds,et al.  5‐Hydroxytryptamine (5‐HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases , 1995, British journal of pharmacology.

[34]  M. Jurzak,et al.  Cloning and Expression of a Human Serotonin 5‐HT4 Receptor cDNA , 1997, Journal of neurochemistry.

[35]  H. Lübbert,et al.  Expression of serotonin receptor mRNAs in blood vessels , 1995, FEBS letters.

[36]  R. Fischmeister,et al.  Cloning, Expression, and Pharmacology of Four Human 5‐Hydroxytryptamine4 Receptor Isoforms Produced by Alternative Splicing in the Carboxyl Terminus , 1998, Journal of neurochemistry.

[37]  E. Tolosa,et al.  Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: comparison with other mammalian species. , 1994, Brain research. Molecular brain research.